Search

everythinglearnresearchcommunity

for

Search:↓

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

BTNL2 helps protect hair follicles from immune attacks.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

Combining oral methylprednisolone with microneedle radiofrequency improves hair growth in alopecia areata but may cause pain and side effects.

Teriflunomide can cause hair thinning.

Intralesional cidofovir might be a good alternative treatment.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Special cells can help regrow hair in alopecia areata.

Baricitinib helps with early hair regrowth in people with alopecia areata.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Children with frequent severe infections and low antibodies should be checked for immune deficiencies.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.